These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-000675-34 A Prospective, Randomized, Controlled, Multi-center, (Pilot) Study of Osigraft® in Instrumented Posterolateral Fusions not-yet-due
Completed, but no date Terminated 2006-004008-38 The Breast CARE Study: Capecitabine (Xeloda®) combined with RHenium-188-HEDP in breast cancer patients with bone metastses; a Re-188-HEDP phase I dose escalation study and phase II efficacy study. bad-data
Ongoing 2006-004482-33 Investigating the acute effects of THC on functional brain systems not-yet-due
Not reported Terminated 2006-004564-32 The Prostate CARE Study: Capecitabine (Xeloda®) combined with Rhenium-188-HEDP in hormone refractory prostate cancer patients with bone metastases; a Capecitabine phase I dose escalation study and ph... 2011-07-01 due-trials
Completed, but no date Terminated 2006-005007-34 Bortezomib re-induction therapy combined with donor lymphocyte infusion in patients with relapsed Multiple Myeloma following allogeneic stem cell transplantation bad-data
Ongoing 2006-005796-18 Does antenatal allopurinol during asphyxia reduce post-hypoxic-ischemic reperfusion damage in the newborn? not-yet-due
Completed, but no date 2006-005913-37 Intratympanic gentamicin therapy for M Meniere: a comparison of two regimes bad-data
Listed as ongoing, but also has a completion date 2006-006295-37 A multi-site RCT comparing regional and general anaesthesia for effects on neurodevelopmental outcome and apnoea in infants. 2018-09-19 bad-data
Completed, report not yet due 2006-006812-31 Multicenter randomized clinical trial in Patients with Juvenile Idiopathic Arthritis and Methotrexate related side effects: Psychological Behavioural therapy versus switch to MTX parenteral versus sta... 2020-08-01 not-yet-due
Ongoing 2007-000033-19 An open study to investigate the effect of 4 instead of 2 daily dosing mycophenolate mofetil (MMF) in renal transplant patients on diarrhea not-yet-due
Ongoing 2007-001855-20 A double blind placebo controlled crossover study to determine the effects of atomoxetine on event-related potentials in response to auditory oddball stimuli during an on-the-road driving test in adul... not-yet-due
Ongoing 2007-001861-14 Multicenter randomized clinical trial in Patients with Juvenile Idiopathic Athritis: Safety and efficacy of vaccination with live attenuated Measles, Mumps, Rubella vaccine not-yet-due
Completed, but no date 2007-002078-71 Reductie van Hersenschade na “Perinatal Arterial Stroke”of PAS met recombinant humaan Erythropoietine (rhEPO): Een “Proof of Concept” en “Safety” studie bad-data
Listed as ongoing, but also has a completion date and reported results 2007-002466-35 A randomised placebo-controlled trial of fixed-dose combination medication in those at raised risk of cardiovascular disease 2010-04-30 bad-data
Completed, but no date 2007-003341-32 Treatment of steroid resistant grade II to IV acute GVHD by infusion of mesenchymal stem cells expanded with human plasma and platelet lysate ; a phase I/II study bad-data
Completed, but no date Terminated 2007-003965-42 Methylphenidate, rivastigmine or haloperidol in hypoactive delirious intensive care patients: a single centre, randomized, mono-blind pilot trial bad-data
Ongoing 2007-004105-10 Effect of palivizumab on respiratory syncytial virus-associated burden of disease – a randomized controlled trial not-yet-due
Other 2007-004247-30 The Role of the Endocannabinoid System in Psychiatric Disorders and Symptoms: a Pharmacological fMRI study not-yet-due
Not reported Terminated 2007-004545-15 The Split Dose Study: Split dose Rhenium-188-HEDP regimen in hormone refractory prostate cancer patients with bone metastases; a phase I toxicity study and phase II efficacy study. 2011-05-03 due-trials
Completed, but no date 2007-004616-31 Prevention of neutrophil induced extracellular matrix damage following skin exposure to solar simulating radiation (SSR) bad-data
Completed, but no date Terminated 2007-005300-41 Rivastigmine for delirium in Intensive Care patients, a double-blind, randomised, placebo-controlled, multi-center add-on trial bad-data
Ongoing 2007-005401-22 Effect of Aliskiren on Muscle Sympathetic Nerve Activity in hypertensive patients with chronic kidney disease not-yet-due
Completed, but no date Terminated 2007-005455-42 ENDO ACE TRIAL bad-data
Not reported 2007-007072-42 Double-blind placebo-controlled randomized study to determine the effectiveness of magnesium oxide to reduce the prostate motion. 2010-05-29 due-trials
Completed, but no date Terminated 2007-007610-10 Prevention of constipation during treatment with opioids: magnesiumoxide versus macrogol/elektrolytes bad-data
Reported results 2008-000560-17 Prednisolone Rhinosinusitis Efficacy Trial (PRET) study 2011-04-28 due-trials
Ongoing 2008-000628-25 The effectiveness of intensive treatment on sympathetic hyperactivity. A randomized, cross-over trial in patients with chronic kidney disease and hypertension not-yet-due
Completed, but no date, and reported results 2008-001597-33 Development of chronic disease in newly diagnosed Idiopathic Thrombocytopenic Purpura of Childhood. A randomized controlled study on the influence of treatment with intravenous gammaglobulin on the co... bad-data
Completed, but no date 2008-002110-22 A randomised sequential trial of Lithium in amyotrophic lateral sclerosis bad-data
Ongoing 2008-003635-20 Maraviroc Immune Recovery Study (MIRS): A multicentre, randomized, placebo-controlled, exploratory mechanistic study into the role of Maraviroc on immune recovery not-yet-due
Ongoing 2008-003908-61 A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, 2-PERIOD, CROSSOVER STUDY TO COMPARE THE EFFECTS OF EZETIMIBE/SIMVASTATIN (10 MG/10 MG) COMBINATION TABLET VERSUS SIMVASTATIN 80 MG TABLET ON POSTPRANDIAL ARTE... not-yet-due
Ongoing 2008-004746-81 Effect of amiloride on lithium-induced chronic nephropathy. Comparing discontinuation of lithium treatment to adding amiloride while continuing lithium treatment. not-yet-due
Ongoing 2008-005426-37 The effect of sevoflurane and isoflurane on vasopressor need not-yet-due
Completed, but no date Terminated 2008-008169-36 Immune response after Human Papillomavirus vaccination in patients with auto-immune disease bad-data
Ongoing 2008-008278-29 Is early revaccination after ALL therapy feasible ? not-yet-due
Completed, but no date 2009-009334-32 Effect of Statins on Sympathetic Activity in Hypertensive Patients with Chronic Kidney Disease: a Randomized trial in Hypertensive Patients with Chronic Kidney Disease bad-data
Ongoing 2009-010921-38 Chemopreventive effects of 5-ASA and UDCA in Ulcerative Colitis: A Double-blind, Randomized Placebo-controlled Pilot Study not-yet-due
Completed, but no date 2009-010967-18 Effect of adding vildagliptin to start of insulin treatment in combination with metformin in patients with type 2 diabetes bad-data
Completed, but no date Terminated 2009-011220-62 A randomized controlled withdrawal trial in Crohn's disease patients in long-term remission on mesalazine: the CROWN study bad-data
Ongoing 2009-012115-18 Primovist enhanced MRI for the detection and evaluation of focal liver lesions not-yet-due
Completed, but no date 2009-013259-31 A multicenter double blind placebo-controlled randomised trial for benign esophageal anastomotic strictures: Savary dilation vs savary dilation with Triamcinolon bad-data
Completed, but no date Terminated 2009-013348-35 (Patho)Physiological aspects of the bile salt-FXR-FGF19-axis: potential consequences in Crohn's disease. bad-data
Completed, but no date 2009-015982-29 A randomized, placebo-controlled, double blind, 4-period, cross-over trial, to study the effects of aliskiren, hydrochlorothiazide and moxonidine on endothelial dysfunction in obesity related hyperten... bad-data
Listed as ongoing, but also has a completion date and reported results 2009-016278-34 UMPIRE - Use of a Multidrug Pill In Reducing cv Events - a randomised controlled trial of fixed dose combination medication and usual care in those at high risk of cardiovascular disease. 2012-07-31 bad-data
Ongoing 2009-016992-31 EUropean Pharmacogenetics of AntiCoagulation Therapy trial not-yet-due
Listed as ongoing, but also has a completion date 2009-016994-13 EUropean Pharmacogenetics of AntiCoagulation Therapy trial 2013-03-25 bad-data
Ongoing 2009-017051-10 Metabolic adverse events before and after glucocorticoid pulse therapy in rheumatoid arthritis not-yet-due
Exempt 2010-019529-33 A Phase l/ll study to assess safety of co-infusion of haematopoietic stem cells from a haplo-identical donor and a single unit unrelated cord blood in high risk patients not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-020185-19 Optimization of Treatment and Management of Schizophrenia in Europe 2017-11-01 bad-data
Completed, but no date 2010-021198-35 D-cycloserine (DCS) enhancement of exposure therapy in panic disorder with agoraphobia: a randomized controlled trial. bad-data
Ongoing 2010-021221-12 A phase I/ II study not-yet-due
Completed, but no date 2010-022641-25 Maraviroc Abacavir STudy – effect on Endothelial Recovery bad-data
Ongoing 2010-022682-98 Monitoring of influenza-like symptoms among elderly, an observational study not-yet-due
Ongoing 2010-022994-32 Effect of N-acetylcysteine on hydrogen sulfide in chronic kidney disease not-yet-due
Completed, but no date Terminated 2010-024327-24 Effect of C1-esterase inhibitor on systemic inflammation in trauma patients with a femur fracture. bad-data
Completed, but no date Terminated 2011-001794-85 Transarterial RAdioembolization versus ChemoEmbolization for the treatment of HCC: A multicenter randomized controlled trial bad-data
Completed, but no date 2011-001815-29 Chemopreventive effects of mesalazine in patients at high risk of recurrent (nonfamilial) colorectal adenomas bad-data
Ongoing 2011-003298-26 A phase IV, randomized, open label, cross-over, intervention trial to investigate the effect of the switch of lopinavir-ritonavir to raltegravir on endothelial function, chronic inflammation, immune a... not-yet-due
Not reported 2011-003470-88 Phenylephrine versus EPhedrine on cerebral Perfusion during carotid EndarteRectomy: PEPPER study 2013-09-19 due-trials
Not reported 2011-004369-34 SPACE trial 2018-01-17 due-trials
Ongoing 2011-005749-10 Safety and Feasibility of TachoSil®: Application on Esophageal Anastomoses. not-yet-due
Completed, but no date Terminated 2011-005971-18 TimeToStop (TTS) Trial, A randomised controlled trial of early versus late antiepileptic drug withdrawal after pediatric epilepsy surgery bad-data
Completed, but no date Terminated 2012-000333-40 Towards plannable breast surgery: diagnostic accuracy of microbubble enhanced Iodine-125 seed localization of the sentinel lymph node (MIB study) bad-data
Completed, but no date Terminated 2012-000605-72 Unrelated cord blood transplantation after reduced toxicity conditioning with mesenchymal stromal cell co-infusion in patients with severe epidermolysis bullosa bad-data
Not reported 2012-000992-18 Proactive versus reactive inhibition in ADHD: Genetics, neurobiology and pharmacology 2016-11-04 due-trials
Exempt, with results 2012-001570-29 Instant MSC Product accompanying Autologous Chondron Transplantation (IMPACT) for focal articular cartilage lesions of the knee; feasibility and safety not-yet-due
Not reported 2012-001909-24 A Multi Center, Prospective, Observational, Open-label, Pharmacokinetic Study of Tacrolimus in Heart and Lung Transplantation Patients during the First Days after Transplantation 2015-09-14 due-trials
Exempt 2012-002067-10 Mesenchymal stromal cells for treatment of drug resistant not-yet-due
Completed, but no date, and reported results 2012-002299-15 The effect of glycopyrroniumbromide on nocturnal clozapine induced sialorrhea in psychiatric patients: a randomized, cross-over, double blind, placebo controlled trial with an extended open label phas... bad-data
Exempt 2012-002435-28 A phase I/II “minor histocompatibility antigen” (mHag)-based Dendritic cell vaccination trial after allogeneic Stem Cell Transplantation to improve the safety and efficacy of donor Lymphocyte infusion... not-yet-due
Ongoing 2012-002604-41 RGNOSIS: Ecological Effects of Decolonisation Strategies in Intensive Care not-yet-due
Ongoing 2013-000531-27 corticosteroids or clobazam for ESES syndrom: a European, multicenter, randomized, controlled clinical trial not-yet-due
Ongoing 2013-000603-16 HYPerbaric OXygen therapy for benign anastomotIC esophageal strictures: a pilot study not-yet-due
Completed, report not yet due Terminated 2013-000834-36 Simvastatin addition to improve symptoms, cognition and metabolic syndrome in patients with recent-onset schizophrenia. 2019-12-19 not-yet-due
Ongoing 2013-003956-18 Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis (JIA) not-yet-due
Ongoing 2013-005395-18 Effects of GLP1 agonist liraglutide in patients with antipsychotic-drugs-associated diabetes mellitus not-yet-due
Completed, but no date 2014-000057-37 A B2-agonist as a CFTR activator in CF bad-data
Ongoing 2014-000112-33 Apixaban versus antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation. A randomised phase II clinical trial. not-yet-due
Not reported 2014-000520-14 Prednisolone addition for atients with recent onset psychotic disorder: the role of immune-modulating strategies in the treatment of psychosis. 2019-05-16 due-trials
Ongoing 2014-000524-26 A randomized, placebo-controlled, double blind, cross-over trial to study the effects of adding bezafibrate to standard lipid lowering therapy on postprandial lipids in patients with familial dysbetal... not-yet-due
Completed, but no date, and reported results 2014-000817-30 Comparing the effect of curcumin and genistein to treatment with Ivacaftor in CF patients with a class III mutation bad-data
Ongoing 2014-001560-35 Bumetanide in Autism Medication and BIomarker study not-yet-due
Ongoing 2014-001912-20 Adult mesenchymal stem cells to regenerate the neonatal brain: the PASSIoN trial (Perinatal Arterial Stroke treated with Stem cells IntraNasally) not-yet-due
Reported results Terminated 2014-002425-35 A Single Centered, Prospective, Open-labeled, Pharmacokinetic Pilot Study of Tacrolimus Administration via Rectiole 2017-12-15 due-trials
Completed, but no date Terminated 2014-002524-27 A randomized, placebo-controlled, double blind, 4-period, cross-over trial, to study blood pressure lowering effects of losartan, Moxonidine and Low sodium diet in former pre-eclamptic women bad-data
Listed as ongoing, but also has a completion date 2014-002765-30 European Long-acting Antipsychotics in Schizofrenia Trial EULAST 2020-08-26 bad-data
Ongoing 2014-003008-53 Clonidine Augmentation Therapy in Schizophrenia not-yet-due
Ongoing 2014-003140-12 Optimizing DMARD-therapy for primary Sjogren's Syndrome - Leflunomide and Hydroxychloroquine combination therapy for patients with primary Sjogren's Syndrome not-yet-due
Ongoing 2014-003965-11 Targeted therapy with Imatinib for treatment of poor prognosis mesenchymal-type resectable colon cancer: a proof-of-concept study in the preoperative window period. not-yet-due
Ongoing 2014-004094-17 Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias. not-yet-due
Completed, but no date 2014-004265-25 2-STEP: A single-centre, phase II study to evaluate the safety, tolerability and pharmacokinetics of 2-Iminobiotin (2-IB) in neonates with gestational age of ≥36 weeks with moderate to severe perinata... bad-data
Ongoing 2014-004297-42 Effect of Switching Atripla to Eviplera on neurocognitive and emotional functioning not-yet-due
Ongoing 2014-004590-16 18F-Choline PET/CT for patients with primary hyperparathyroidism and negative SPECT/CT not-yet-due
Not reported 2014-004849-26 PARACHUTE-trial 2019-09-01 due-trials
Ongoing 2014-005127-27 Markers of Efficacy of Xolair (Omalizumab) in Chronic Spontaneous Urticaria not-yet-due
Ongoing 2015-000056-23 89Zr-rituximab PET/CT for detection of central nervous system lymphoma not-yet-due
Ongoing 2015-000168-32 Mesenchymal stem cells for Angiogenesis and Neovascularization in digital Ulcers of Systemic sclerosis not-yet-due
Exempt 2015-000827-94 A phase I/II post cord blood HCT dendritic cells vaccination trial directed against WT1 for pediatric acute myeloid leukemia: the U-DANCE-anti-AML trial not-yet-due
Ongoing 2015-000828-28 Titlle: Subcutaneous immunoglobulins with rHuPH20 in multifocal motor neuropathy (MMN) not-yet-due
Completed, but no date Terminated 2015-001317-28 A B2-agonist as a CFTR activator in CF - Part 2 bad-data
Other 2015-002340-14 Randomized, Embedded, Multifactorial, Adaptive Platform trial for Community-Acquired Pneumonia Coronavirus COVID-19 (REMAP-CAP-COVID-19) not-yet-due
Ongoing 2015-002997-18 Darbepoetin for Ischemic Neonatal Stroke to Augment Regeneration not-yet-due
Ongoing 2015-003179-32 PREvention of Complications to Improve Outcome in elderly patients with acute Stroke. A randomised, open, phase III, clinical trial with blinded outcome assessment. not-yet-due
Other 2015-003503-39 Placebo-controlled Trial in Subjects at Ultra-high Risk for Psychosis With Omega-3 Fatty Acids in Europe not-yet-due
Ongoing 2015-004393-16 Biomarker-guided treatment-and-stop-strategy for recombinant IL-1receptor antagonist (anakinra) in patients with systemic Juvenile Idiopathic Arthritis. not-yet-due
Ongoing 2015-004483-11 Raloxifene Augmentation in Patients with a Schizophrenia spectrum Disorder to reduce symptoms and improve cognition not-yet-due
Not reported Terminated 2015-004858-17 REMission INDuction in very early Rheumatoid Arthritis 2019-02-05 due-trials
Not reported Terminated 2015-005736-17 Prevention of severe infectious complications after colorectal surgery using antimicrobial decontamination of the digestive tract (PreCaution trial) 2018-08-22 due-trials
Exempt 2016-000092-24 The PLCRC substudy Ultra high field 7.0 Tesla MR Spectroscopy to monitor capecitabine metabolism in liver metastases – a proof of concept study not-yet-due
Other 2016-000222-19 Effect of ALlopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome – a blinded randomized placebo-controlled parallel group multicenter trial for superiority ... not-yet-due
Ongoing 2016-001401-16 The SUGAR-DIP trial: Oral medication strategy versus insulin for diabetes in pregnancy not-yet-due
Ongoing 2016-001440-18 Pharmacokinetic interactions between ivacaftor and cytochrome P450 3A4 inhibitors in cystic fibrosis patients and healthy controls not-yet-due
Ongoing 2016-001619-19 Genistein as an add-on treatment for CF? not-yet-due
Not reported 2016-002014-52 DUAL HOMING MECHANISMS OF EOSINOPHILS TO THE SPUTUM; ONLY ONE OF WHICH IS SENSITIVE FOR MEPOLIZUMAB 2019-10-28 due-trials
Ongoing 2016-002086-54 A randomized trial of the effect of antiplatelet therapy (Aspirin, Aspirin and Clopidogrel or Ticagrelor) on the occurrence of atherothrombotic and cardiovascular adverse events following lower extrem... not-yet-due
Ongoing 2016-002408-13 Bumetanide to Ameliorate Tuberous Sclerosis Complex Hyperexcitable Behaviors not-yet-due
Completed, but no date Terminated 2016-002595-27 Cytoreductive surgery and Intraperitoneal chemotherapy and for Stomach CAncer: a feasibility study bad-data
Ongoing 2016-002875-81 Bumetanide for the Autism Spectrum Clinical Effectiveness Trial not-yet-due
Exempt 2016-003643-10 Modulating regulatory T cell function in JIA with Vitamin B3 (nicotinamide) treatment not-yet-due
Ongoing 2016-004486-37 FOsfomycin Randomised controlled trial for E.coli Complicated urinary tract infections as Alternative Stepdown Treatment not-yet-due
Ongoing 2016-005083-34 Conestat alfa as prophylactic treatment for idiopathic non-histaminergic acquired angioedema not-yet-due
Ongoing 2016-005086-31 Multicentre Randomised trial of Acute Stroke treatment in the Ambulance with a nitroglycerine Patch not-yet-due
Ongoing 2017-000332-34 Topical or oral antibiotics for children with acute otitis media presenting with ear discharge? not-yet-due
Ongoing 2017-000369-54 Intra-arterial Lutetium-177- dotatate for treatment of patients with neuroendocrine tumor liver metastases not-yet-due
Ongoing 2017-000393-11 ’Switching anticoagulant management from a VKA to a NOAC-based treatment strategy in frail elderly patients with atrial fibrillation (FRAIL-AF study) not-yet-due
Ongoing 2017-001983-39 A placebo-controlled double blind randomized trial to investigate the efficacy and safety of the combination of Penicillin G / Hydrocortisone treatment in ALS patients (PHALS). not-yet-due
Ongoing 2017-002097-38 SAMe as an epigenetic treatment of depression in people with childhood trauma, a double blind placebo-controlled trial not-yet-due
Ongoing 2017-002494-19 Dexamethasone for Cardiac Surgery trial: a novel 'Standard Practice Preference-Randomised Consent' Design. A PILOT STUDY not-yet-due
Ongoing 2017-003037-28 Efficacy of TOcilizumab in comparison to Prednisone In Rheumatoid Arthritis patients with insufficient response to disease modifying anti-rheumatic drugs. not-yet-due
Ongoing 2017-003777-34 Proton pump inhibition for secondary hemochromatosis in hereditary anemia, a phase III placebo controlled randomized cross-over clinical trial. not-yet-due
Ongoing 2017-003900-28 A Stratification trial to determine key immunological factors predicting Tofacitinib efficacy and drug free remission in Psoriatic Arthritis (PsA). TOFA-PREDICT not-yet-due
Ongoing 2017-004307-51 Complement C5 Antibodies for decreasing brain injury after aneurysmal Subarachnoid Hemorrhage: safety and proof-of-concept. not-yet-due
Ongoing 2017-004596-31 CeRebrUm and CardIac protection with Allopurinol in neonates with critical congenital heart disease requiring cardiac surgery with cardiopulmonary bypass not-yet-due
Ongoing 2018-000356-18 Individualized dosing of fludarabine during innate allo SCT: A randomized phase II study (TARGET Study) not-yet-due
Ongoing 2018-000752-18 Ajmaline provocation in asymptomatic PLN and PKP2 mutation carriers for early detection of Arrhythmogenic Cardiomyopathy not-yet-due
Reported results 2018-002008-15 Optimal cerebral perfusion after an extracranial-intracranial bypass: should we increase blood pressure or cardiac output? 2019-07-22 due-trials
Exempt 2018-002245-11 Assessing penetration of high dose Nicotinamide (Vitamin B3) in synovial fluid not-yet-due
Exempt 2018-002742-37 Effect of intranasal administration of palivizumab on respiratory syncytial virus-associated infection – a randomized controlled trial not-yet-due
Ongoing 2018-003470-27 Randomized controlled trial on clinical outcomes and safety of Instant MSC Product accompanying Autologous Chondron Transplantation (IMPACT) for focal articular cartilage lesions of the knee not-yet-due
Ongoing 2018-003476-12 A multicenter, randomized, double-blind, placebo-controlled, crossover trial to evaluate the effects of evolocumab added to standard lipid-lowering therapy on fasting and post fat load lipids in patie... not-yet-due
Ongoing 2019-002452-16 Inhibition of Mast cell Activation in AtheroScleroTic lesions using an Anti-IgE antibody approach (MAST-trial) not-yet-due
Ongoing 2019-002635-28 The effect of hyperbaric oxygen therapy on breast cancer patients with late radiation toxicity not-yet-due
Completed, report not yet due Terminated 2019-003068-39 Withdrawal of Infliximab in patients with inflammatory bowel disease in remission guided by pharmacokinetics: WINK study 2020-11-18 not-yet-due
Ongoing 2019-004718-32 Upfront autologous hematopoietic stem cell transplantation versus immunosuppressive medication in early diffuse cutaneous systemic sclerosis: an international multicentre, open-label, randomized contr... not-yet-due
Other 2019-004914-32 Sentinel lymph node (SLN) detection in early oral cancer using Gallium-68-Tilmanocept PET-CT not-yet-due
Exempt 2019-004987-23 A Dose-Escalating Phase I/II Study in Patients with RAS-Mutated Metastatic Colorectal Cancer to Investigate Safety and Clinical Activity of the Triple Combination of: MEK-inhibitor binimetinib, Pan-EG... not-yet-due
Ongoing 2020-000053-27 The MEtformin-LIfestyle in Antipsychotic users trial (MELIA): optimizing the use of metformin in the management of antipsychotic-induced weight gain. not-yet-due
Ongoing 2020-000313-33 ‘Bronchodilators for wheeze in young children presenting to primary care: a randomised, placebo-controlled, multicentre, parallel group trial’ not-yet-due
Ongoing 2020-000878-15 Sentinel node Navigation surgery in early esophageal Adenocarcinoma Patients with lymph node involvement: SNAP-IV study not-yet-due
Ongoing 2020-001340-25 Enrichment randomized double-blind, placebo-controlled cross-over trial with PHEnytoin cream in patients with painful chronic idiopathic axonal polyNEuropathy not-yet-due
Other 2020-002503-19 BCG vaccination to Reduce the impact of COVID-19 in healthcare workers following Coronavirus Exposure (BRACE) Trial not-yet-due
Ongoing 2020-003470-47 BACILLUS CALMETTE-GUÉRIN VACCINATION TO PREVENT SERIOUS RESPIRATORY TRACT INFECTION AND COVID-19 IN VULNERABLE ELDERLY – AN ADAPTIVE RANDOMIZED CONTROLLED TRIAL not-yet-due